Viewing Study NCT00556205


Ignite Creation Date: 2025-12-25 @ 3:17 AM
Ignite Modification Date: 2026-03-29 @ 8:05 AM
Study NCT ID: NCT00556205
Status: WITHDRAWN
Last Update Posted: 2016-03-24
First Post: 2007-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module